These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34442430)

  • 21. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.
    Zeng L; Guo P; Li JG; Han F; Li Q; Lu Y; Deng XW; Zhang QY; Lu TX
    Oncotarget; 2015 Nov; 6(36):39373-83. PubMed ID: 26415223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the survival of patients with pancreatic neuroendocrine neoplasms using deep learning: A study based on Surveillance, Epidemiology, and End Results database.
    Jiang C; Wang K; Yan L; Yao H; Shi H; Lin R
    Cancer Med; 2023 Jun; 12(11):12413-12424. PubMed ID: 37165971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China.
    Wen DW; Lin L; Mao YP; Chen CY; Chen FP; Wu CF; Huang XD; Li ZX; Xu SS; Kou J; Yang XL; Ma J; Sun Y; Zhou GQ
    Radiother Oncol; 2021 Apr; 157():99-105. PubMed ID: 33484752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration.
    Huang B; Chen T; Zhang Y; Mao Q; Ju Y; Liu Y; Wang X; Li Q; Lei Y; Ren Y
    Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma.
    OuYang PY; Shi D; Sun R; Zhu YJ; Xiao Y; Zhang LN; Zhang XH; Chen ZY; Lan XW; Tang J; Gao YH; Ma J; Deng W; Xie FY
    Oncotarget; 2016 May; 7(22):33408-17. PubMed ID: 27058901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients.
    Ren J; Liu D; Li G; Duan J; Dong J; Liu Z
    Front Cardiovasc Med; 2022; 9():923549. PubMed ID: 35811691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of machine learning models and Cox proportional hazards models regarding their ability to predict the risk of gastrointestinal cancer based on metabolic syndrome and its components.
    Tran TT; Lee J; Gunathilake M; Kim J; Kim SY; Cho H; Kim J
    Front Oncol; 2023; 13():1049787. PubMed ID: 36937438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups.
    Zhuo EH; Zhang WJ; Li HJ; Zhang GY; Jing BZ; Zhou J; Cui CY; Chen MY; Sun Y; Liu LZ; Cai HM
    Eur Radiol; 2019 Oct; 29(10):5590-5599. PubMed ID: 30874880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grading Soft Tissue Involvement in Nasopharyngeal Carcinoma Using Network and Survival Analyses: A Two-Center Retrospective Study.
    Dong A; Huang W; Ma H; Cui C; Zhou J; Ruan G; Liang S; Liu L; Li H
    J Magn Reson Imaging; 2021 Jun; 53(6):1752-1763. PubMed ID: 33598979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of modified-DeepSurv in overall survivals of patients with lung cancer.
    Lei J; Xu X; Xu J; Liu J; Wang Y; Wu C; Zhang R; Zhang Z; Jiang T
    iScience; 2023 Nov; 26(11):108200. PubMed ID: 38033628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep-Learning-Based Survival Prediction of Patients in Coronary Care Units.
    Yang R; Huang T; Wang Z; Huang W; Feng A; Li L; Lyu J
    Comput Math Methods Med; 2021; 2021():5745304. PubMed ID: 34976110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep learning pathological microscopic features in endemic nasopharyngeal cancer: Prognostic value and protentional role for individual induction chemotherapy.
    Liu K; Xia W; Qiang M; Chen X; Liu J; Guo X; Lv X
    Cancer Med; 2020 Feb; 9(4):1298-1306. PubMed ID: 31860791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
    Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interrupted time during intensity modulated radiation therapy on survival outcomes in patients with nasopharyngeal cancer.
    Xu GZ; Li L; Zhu XD
    Oncotarget; 2017 Jun; 8(23):37817-37825. PubMed ID: 27911864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
    Li PJ; Mo HY; Luo DH; Hu WH; Jin T
    Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.